Maternal depressive symptoms during pregnancy are associated with risk for offspring emotional and behavioral problems, but the mechanisms by which this association occurs are not known. Infant elevated negative affect (increased crying, irritability, fearfulness, etc.) is a key risk factor for future psychopathology, so understanding its determinants has prevention and early intervention potential. An understudied yet promising hypothesis is that maternal mood affects infant mood via maternal prenatal inflammatory mechanisms, but this has not been prospectively examined in humans. Using data from a pilot study of women followed from the second trimester of pregnancy through six months postpartum (N = 68) our goal was to initiate a prospective study as to whether maternal inflammatory cytokines mediate the association between maternal depressive symptoms and infant offspring negative affect. The study sample was designed to examine a broad range of likely self-regulation and mood-regulation problems in offspring; to that end we over-selected women with a family history or their own history of elevated symptoms of attention-deficit/hyperactivity disorder. Results supported the hypothesis: maternal pro-inflammatory cytokines during the third trimester (indexed using a latent variable that included plasma interleukin-6, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 concentrations as indicators) mediated the effect, such that higher maternal depressive symptoms were associated with higher maternal inflammation, and this mediated the effect on maternal report of infant negative affect (controlling for maternal affect during the infant period). This is the first human study to demonstrate that maternal inflammatory cytokines mediate the association between prenatal depression and infant outcomes, and the first to demonstrate a biological mechanism through which depressive symptoms impact infant temperament.
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Introduction
Even without meeting full Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for a major depressive episode, maternal depressive symptoms during pregnancy (hereafter referred to as prenatal depressive symptoms) are associated with emotional and behavioral problems in offspring, notably including heightened negative affect during infancy (Davis et al., 2007; Davis et al., 2004; McGrath et al., 2008) , which is a key marker of risk. Negative affect commonly manifests as increased crying, anger, fearfulness, and fearful reactivity when presented with a novel stimulus. Negative affect is a robust, empirically well-established higher order factor in temperament (Gartstein and Rothbart, 2003; Rothbart et al., 2000) and is a risk factor for multiple psychopathologies (Muris and Ollendick, 2005; Nigg, 2006; Rothbart, 2007) , making its early manifestations important. With an association between maternal prenatal mood and infant negative affect becoming increasingly clear, understanding the biological mechanisms through which this risk (itself a mix of genetic and environmental distal factors) is conveyed becomes an important opportunity for mapping pathways to psychopathology in children.
According to the developmental origins of health and disease (DOHaD) hypothesis (Gluckman, 2010), women's experiences and psychological states during pregnancy alter the in utero environment, in turn shaping the development of the fetal brain and can contribute to long-term mood and behavior traits. Paternal pre-conception stress, nutrition, and physiological status are also increasingly recognized as
